跳至主要内容
临床试验/CTRI/2018/09/015772
CTRI/2018/09/015772尚未招募2 期

Investigating the efficacy of dual stimulation of tDCS and rTMS Neuro-modulation therapy of Major depression - DNIBS-MD

Director NIMHANS0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Individuals with a diagnosis of moderate or severe depression according to ICD-10 diagnosed by a psychiatrist would be recruited if they continue to have at least moderate depressive symptoms as defined clinically and using the HDRS cut-off score of more than 17 even after at least 4-weeks of adequate antidepressant trial with any conventional antidepressant medication

排除标准

  • 1.Patients aged < 18 and > 60 years of age
  • 2.If patient is on any psychotropic (other than antidepressant medications, which is kept constant throughout the study period unless clinically required), anticholinergic or cardiac medications
  • 3.Patients with suicidal tendencies or psychotic depression
  • 4.Patients with any co-morbid cardiac or neurological disorders that can increase the risk of TMS related complications or are having a contraindication for TMS/tDCS treatment
  • 5.Pregnant/lactating patients
  • 6.Failure of other organ systems or systemic illness that could affect autonomic function or participantsâ?? ability to cooperate

研究者

发起方
Director NIMHANS

相似试验